Using synovial explants from patients with RA, therapeutic intervention with a combination of biologicals, e.g., anti-TNF-α antibodies and IL-1Ra, resulted in significantly decreased IL-6 and MMP-3 production, indicating the superior efficacy of combinatorial therapy over a single biological treatment [70]. This evidence concerns the gene IL6 and rheumatoid arthritis.